Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | 
|---|---|---|---|
| 1 | |||
| Extravasation | common | x | |
| Body temperature increased | common | x | |
| Pain | common | x | |
| Phlebitis | common | x | |
| Swelling | common | x | |
| Redness | common | x | |
| Acute respiratory distress syndrome | rare | x | |
| Drug interaction | rare | x | |
| Abdominal pain | x | ||
| Anaemia | x | ||
| Cyst | x | ||
| Diarrhoea | x | ||
| Gastrointestinal disorder | x | ||
| Hepatitis | x | ||
| Leukopenia | x | ||
| Mediastinal disorder | x | ||
| Nausea | x | ||
| Neoplasm | x | ||
| Nervous system disorder | x | ||
| Pancytopenia | x | ||
| Paraesthesia | x | ||
| Polyp | x | ||
| Pruritus | x | ||
| Thrombocytopenia | x | ||
| Urinary tract disorder | x | ||
| Vomiting | x | ||
| Unspecified disorder of skin and subcutaneous tissue | x | ||
| Hepatobiliary disease | x | ||
| Gastrointestinal toxicity | x | ||
| Ageusia | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Malignant melanoma | x | ||
| Metastasis | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |